A trial to examine the impact of denosumab on diabetes, in terms of whether it delays the development of diabetes

Trial Profile

A trial to examine the impact of denosumab on diabetes, in terms of whether it delays the development of diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2016

At a glance

  • Drugs Denosumab (Primary) ; Etidronic acid; Risedronic acid; Zoledronic acid
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2016 New trial record
    • 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top